rs374911318
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000258888.6(ALPK3):c.1828G>A(p.Val610Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000836 in 1,614,070 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. V610V) has been classified as Likely benign.
Frequency
Consequence
ENST00000258888.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALPK3 | NM_020778.5 | c.1828G>A | p.Val610Met | missense_variant | 6/14 | ENST00000258888.6 | NP_065829.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALPK3 | ENST00000258888.6 | c.1828G>A | p.Val610Met | missense_variant | 6/14 | 1 | NM_020778.5 | ENSP00000258888 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152194Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251368Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135862
GnomAD4 exome AF: 0.0000896 AC: 131AN: 1461876Hom.: 0 Cov.: 30 AF XY: 0.0000921 AC XY: 67AN XY: 727234
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152194Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74352
ClinVar
Submissions by phenotype
not provided Pathogenic:1Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Feb 07, 2024 | Identified in the heterozygous and compound heterozygous state in patients with DCM (PMID: 32480058, 30847666); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Also known as p.(V812M); This variant is associated with the following publications: (PMID: 30847666, 32480058, 33076350) - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 812 of the ALPK3 protein (p.Val812Met). This variant is present in population databases (rs374911318, gnomAD 0.004%). This missense change has been observed in individual(s) with ALPK3-related disease (PMID: 32480058). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 504883). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The methionine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 03, 2017 | Variant classified as Uncertain Significance - Favor Benign. The p.Val812Met var iant in ALPK3 has not been reported in any other families with cardiomyopathy, b ut has been identified in 5/126652 European chromosomes by the Genome Aggregatio n Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs374911318). Valine (Val) at position 812 is not evolutionarily conserved and 3 mammals (bushbaby, Chinese tree shrew, and Weddell seal) carry a methionine (Met) at this position, raising the possibility that this change may be tolerated. In summary, while th e clinical significance of the p.Val812Met variant is uncertain, its identificat ion in other species suggests that it is more likely to be benign. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 11, 2023 | The p.V812M variant (also known as c.2434G>A), located in coding exon 6 of the ALPK3 gene, results from a G to A substitution at nucleotide position 2434. The valine at codon 812 is replaced by methionine, an amino acid with highly similar properties. This variant was detected in two siblings diagnosed with neonatal-onset cardiomyopathy who both also had a truncating ALPK3 variant in trans (Herkert JC et al. Am. Heart J., 2020 07;225:108-119). Additionally, this variant was detected as heterozygous in a cardiomyopathy genetic testing cohort; however, clinical details were limited. (van Lint FHM et al. Neth Heart J, 2019 Jun;27:304-309). This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at